Four-Dimensional Symptom Questionnaire (4DSQ)

1. Abstract

The Four-Dimensional Symptom Questionnaire (4DSQ) is a comprehensive self-report psychological instrument developed by Berend Terluin to delineate non-specific psychological distress from formal psychiatric morbidity in primary health care and occupational settings. Comprising 50 items across four distinct subscales—Distress (16 items), Depression (6 items), Anxiety (12 items), and Somatization (16 items)—the instrument assesses psychological and psychosomatic symptoms experienced during the preceding week. The questionnaire employs a unique three-level scoring protocol derived from an underlying five-point frequency scale: responses of "no" are scored 0 points, "sometimes" is scored 1 point, and "regularly", "often", and "very often or constantly" are collapsed into 2 points to reduce the confounding influence of transient symptom intensity while isolating frequency and chronicity. The 4DSQ was engineered specifically to overcome the diagnostic dilemma presented by conventional operational criteria, such as those within the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV and DSM-5), which frequently generate high rates of false-positive diagnoses by categorizing general stress-related distress as major depressive or anxiety disorders. Across diverse clinical and non-clinical cohorts, the 4DSQ displays robust psychometric integrity. Internal consistency reliabilities (Cronbach’s alpha) regularly exceed .80 across all four domains (Distress: .90; Depression: .82–.90; Anxiety: .79–.88; Somatization: .80–.84). Confirmatory factor analyses consistently validate its four-dimensional structural architecture, showing clear discriminant validity between distress and true mood or anxiety pathology. By maintaining calibrated diagnostic cut-offs for moderate and severe elevations across each subscale, the 4DSQ serves as an essential tool for triage, clinical decision-making, and therapeutic outcome monitoring in general practice, occupational medicine, and psychosomatic research.

2. Keywords

Four-Dimensional Symptom Questionnaire, 4DSQ, distress, somatization, anxiety, depression, primary care psychometrics, Berend Terluin, psychological assessment, differential diagnosis

3. Authors

The primary author and architect of the Four-Dimensional Symptom Questionnaire is Dr. Berend Terluin, MD, PhD. Dr. Terluin is a general practitioner and senior academic researcher associated with the Department of General Practice and Elderly Care Medicine at the Amsterdam University Medical Centers (Amsterdam UMC), Vrije Universiteit Amsterdam, based in Amsterdam, the Netherlands. His investigative program has centered on the phenomenology, classification, epidemiology, and clinical management of common mental disorders and stress-related psychological syndromes within primary care and occupational environments.

Major psychometric validation initiatives and collaborative theoretical modeling of the 4DSQ have been conducted alongside prominent academic co-investigators, including:

• Willem van Rhenen, MD, PhD: Professor of Occupational Health at Nyenrode Business University and Chief Medical Officer at ArboNed, Utrecht, the Netherlands.
• Wilmar B. Schaufeli, PhD: Distinguished Professor of Work and Organizational Psychology at Utrecht University, the Netherlands, and KU Leuven, Belgium, recognized for foundational contributions to the assessment of burnout and occupational distress.
• Harm W. J. van Marwijk, MD, PhD: Professor of General Practice, formerly at Amsterdam UMC and subsequently at the Brighton and Sussex Medical School, United Kingdom.
• Brenda W. J. H. Penninx, PhD: Professor of Psychiatric Epidemiology at the Department of Psychiatry, Amsterdam UMC, and Principal Investigator of the Netherlands Study of Depression and Anxiety (NESDA).
• Hiekje C. W. de Vet, PhD: Professor of Clinimetrics at the Department of Epidemiology and Data Science, Amsterdam UMC.

Correspondence regarding the instrument, permission requests, and psychometric documentation can be directed to Dr. Berend Terluin via the Amsterdam Public Health research institute, Amsterdam UMC, Location VUmc, Van der Boechorststraat 7, 1081 BT Amsterdam, the Netherlands.

4. Purpose

The fundamental purpose of the Four-Dimensional Symptom Questionnaire (4DSQ) is to resolve the profound diagnostic and conceptual challenges that emerge when evaluating mental health complaints within primary care, occupational health, and community medicine. In specialized psychiatric settings, patients frequently present with high symptom severity, clear syndromal clustering, and pervasive functional impairment that aligns straightforwardly with categorical classification frameworks such as the DSM-5 or the International Classification of Diseases (ICD-11). In contrast, patients consulting general practitioners or occupational physicians present with heterogeneous, undifferentiated, and fluctuating symptom presentations. A substantial proportion of these complaints represent physiological and psychological strain in response to psychosocial stressors—a state clinically operationalized as distress—rather than structural psychiatric disorders.

When clinicians indiscriminately apply conventional psychiatric criteria designed for tertiary psychiatric cohorts to primary care populations, significant diagnostic misclassification occurs. Symptoms such as fatigue, insomnia, poor concentration, muscle tension, and dysphoria are diagnostic criteria for Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD), yet they are equally the cardinal manifestations of non-pathological stress responses, adjustment disorders, and burnout. As a consequence, conventional assessment tools yield substantial false-positive rates, leading to inappropriate medicalization, unnecessary prescription of antidepressant pharmacotherapy, inflated healthcare costs, and patient distress caused by stigmatizing psychiatric labels.

The 4DSQ was created specifically to operationalize and validate a four-way clinical taxonomy that delineates:

• Distress: General, stress-related emotional strain, wear-and-tear, and temporary exhaustion of coping mechanisms.
• Depression: True depressive pathology characterized by pervasive anhedonia, loss of interest, and core depressive cognitions that warrant targeted evidence-based clinical interventions.
• Anxiety: Specific irrational fears, phobic avoidance, and free-floating or paroxysmal panic states indicative of anxiety disorders.
• Somatization: Physical symptoms mediated by autonomous nervous system arousal or somatic hyper-responsiveness that lack organic pathology.

In clinical practice, the 4DSQ serves four primary objectives: First, it facilitates communicative validation, helping patients who consult with somatic complaints (e.g., tension headaches, functional dyspepsia, palpitations) recognize the psychophysiological underpinnings of their symptoms. Second, it quantifies the overall severity of general mental strain to monitor spontaneous recovery or identify chronic decompensation. Third, it acts as a selective case-finding instrument to detect depressive and anxiety disorders that have surpassed the threshold of normal stress responses and necessitate targeted psychotherapy or pharmacotherapy. Fourth, it provides longitudinal evaluation metrics to monitor clinical response, relapse, and return-to-work readiness during occupational rehabilitation.

5. Psychological Construct

The 4DSQ evaluates four distinct yet intercorrelated dimensions of common psychological and psychosomatic suffering. Understanding these specific constructs is vital for correctly interpreting its profile scores.

Distress (16 Items)

The Distress construct represents the universal biobehavioral reaction to environmental stressors, role overload, interpersonal conflict, or traumatic life events. It captures the psychological state wherein an individual’s coping capacity is taxed near or beyond its operating limits. Phenomenologically, distress encompasses mental exhaustion, irritability, demoralization, subjective tension, sleep disturbances, cognitive sluggishness, and non-specific emotional lability. Illustrative items include feeling "tense", being "easily irritated", experiencing "disturbed sleep", "worry", "lack of energy", and feeling "that you can’t cope anymore". Crucially, distress is conceptualized as an adaptive or understandable reaction to stress rather than an autonomous mental disease entity. It represents an elevated level of psychological entropy that typically subsides once stressors resolve or adaptive coping mechanisms are re-established.

Depression (6 Items)

In stark contrast to general distress, the Depression construct in the 4DSQ is tightly restricted to the core symptoms of severe, anhedonic depressive illness (analogous to melancholic or autonomous major depression). Rather than measuring demoralization or transient sorrow, the 6 items capture profound anhedonia, loss of meaning, pervasive hopelessness, and suicidal ideation. Items assess beliefs "that everything is meaningless", "that life is not worth while", "that you can no longer take any interest in the people and things around you", "that you can’t enjoy anything anymore", "that you would be better off if you were dead", and explicitly thinking "I wish I was dead". By excluding non-specific symptoms such as fatigue, insomnia, and appetite changes—which overlap heavily with distress and physical illness—the 4DSQ Depression scale maintains high diagnostic specificity for depressive illness requiring formal psychiatric management.

Anxiety (12 Items)

The Anxiety construct captures symptoms of specific anxiety disorders, including panic disorder, agoraphobia, social anxiety disorder, obsessive-compulsive phenomena, and specific phobias. It focuses on symptoms of pathological, autonomous fear that lack proportionality to immediate environmental threats. Symptoms include paroxysmal autonomic surges ("sudden fright for no reason", "anxiety or panic attacks"), anticipatory anxiety and phobic avoidance ("fear of going out of the house alone", "afraid to travel on buses, streetcars/trams, subways or trains", "avoid certain places because they frightened you"), social evaluative terror ("trembling when with other people", "afraid of becoming embarrassed when with other people"), generalized apprehension ("a vague feeling of fear", "threatened by unknown danger"), and compulsive behaviors ("repeat some actions a number of times before you could do something else"). This scale differentiates clinical anxiety syndromes from the generalized worry and nervous tension captured within the Distress scale.

Somatization (16 Items)

The Somatization construct measures functional somatic symptoms that represent physiological hyper-reactivity, somatic manifestations of stress, or medically unexplained physical symptoms. The scale samples bodily sensations across major physiological domains: neuromuscular tension ("painful muscles", "neck pain", "back pain", "headache"), autonomic and cardiopulmonary arousal ("palpitations", "shortness of breath", "pressure or a tight feeling in the chest", "pain in the chest", "excessive sweating"), vestibular and neurosensory disturbances ("dizziness or feeling light-headed", "fainting", "blurred vision or spots in front of your eyes", "tingling in the fingers"), and gastrointestinal sensitivity ("nausea or an upset stomach", "a bloated feeling in the abdomen", "pain in the abdomen or stomach area"). The Somatization scale enables healthcare providers to quantify somatic distress independently of cognitive-emotional distress.

6. Theoretical Framework

The theoretical architecture of the 4DSQ is grounded in the tripartite and dimensional paradigms of psychopathology, the cognitive-activation theory of stress, and the clinimetric critique of categorical psychiatric nosology pioneered by Alvan Feinstein.

A primary theoretical influence is the Tripartite Model of Anxiety and Depression formulated by Lee Anna Clark and David Watson (1991). Clark and Watson posited that anxiety and depression share a broad, non-specific dimension of Negative Affectivity (general distress), while being differentiated by specific psychopathological components: physiological hyperarousal characterizes anxiety, whereas low positive affectivity (anhedonia) uniquely characterizes depression. Terluin extended this formulation to primary care clinimetrics by establishing Distress as the core manifestation of negative affectivity. In the 4DSQ framework, distress is conceptualized as the non-specific, foundational response of human beings to severe or prolonged environmental adversity. Depression and anxiety, conversely, are viewed as specific syndromal departures from this primary baseline, emerging when stress triggers autonomous neurobiological and cognitive vulnerabilities.

The 4DSQ is also informed by Cognitive Activation Theory of Stress (CATS), developed by Holger Ursin and Hege R. Eriksen. CATS conceptualizes psychological stress as an adaptive alarm response triggered by discrepancies between actual and expected situations. When an individual lacks a positive coping outcome expectancy, prolonged activation of the sympathetic-adrenomedullary and hypothalamic-pituitary-adrenal (HPA) axes occurs, resulting in the physiological complaints measured by the Somatization scale and the psychological exhaustion measured by the Distress scale. If coping failure persists, demoralization ensues, potentially transitioning into severe helplessness and hopelessness—the cognitive markers captured by the 4DSQ Depression scale.

From a clinimetric perspective, Terluin rejected the DSM’s categorical premise that all combinations of somatic, affective, and cognitive complaints above an arbitrary threshold constitute mental disorders. The 4DSQ was engineered under the assumption that distress and somatization operate as continuous, physiological parameters of human adaptation, whereas clinical depression and anxiety represent distinct, disabling psychopathological configurations. By measuring these dimensions simultaneously on orthogonal yet correlated axes, the 4DSQ operationalizes a biopsychosocial assessment model suitable for front-line medical decision-making.

7. Validity

The psychometric validity of the 4DSQ has been rigorously established in primary care patients, occupational cohorts, psychiatric outpatient clinics, and general population samples.

Construct and Factorial Validity

In the seminal validation investigation by Terluin et al. (2006) involving 2,127 primary care patients, confirmatory factor analyses verified that the proposed four-factor model exhibited superior fit relative to alternative unidimensional, two-dimensional (combining distress with depression, and somatization with anxiety), and three-dimensional models. Inter-factor correlations confirmed theoretical expectations: Distress correlated moderately with Depression ($r \approx .58$), Anxiety ($r \approx .60$), and Somatization ($r \approx .51$), while the correlation between Depression and Somatization was notably lower ($r \approx .34$), confirming that Distress occupies a central position as the common denominator of affective disturbance, while Depression and Somatization reflect distinct symptomatic poles.

Convergent and Discriminant Validity

Convergent validity has been established across multiple studies benchmarking the 4DSQ against gold-standard psychometric scales:

• The 4DSQ Depression scale correlates strongly ($r = .75$ to $.83$) with the Beck Depression Inventory (BDI) and the depression subscale of the Hospital Anxiety and Depression Scale (HADS-D).
• The 4DSQ Anxiety scale correlates robustly ($r = .70$ to $.78$) with the State-Trait Anxiety Inventory (STAI) and HADS-A.
• The 4DSQ Distress scale correlates highly with the Maslach Burnout Inventory exhaustion subscale ($r = .72$) and the Perceived Stress Scale ($r = .76$).
• The 4DSQ Somatization scale demonstrates strong convergence ($r = .74$ to $.80$) with the Patient Health Questionnaire-15 (PHQ-15) and the SCL-90 Somatization subscale.

Discriminant validity was demonstrated by Terluin, Brouwers, et al. (2009) in a study examining 387 primary care patients. When compared against the Composite International Diagnostic Interview (CIDI) for DSM-IV diagnoses, the 4DSQ Depression scale yielded an Area Under the Receiver Operating Characteristic Curve (AUC) of 0.87 for Major Depressive Disorder, significantly outperforming general distress measures. Crucially, the Distress scale discriminated patients experiencing acute work-related stress and adjustment disorders from non-stressed controls, but did not misclassify uncomplicated stress as depressive disorder, confirming its diagnostic specificity.

Criterion and Predictive Validity

Criterion-related validity studies in occupational medicine (Terluin et al., 2004) demonstrated that elevated scores on the Distress scale accurately predicted future long-term sickness absence (hazard ratio 2.14 for scores > 20). In longitudinal primary care tracking, reduction in 4DSQ subscale scores parallels functional recovery measured by the SF-36 Health Survey, demonstrating sensitivity to clinical change following psychological or pharmacological interventions.

8. Reliability

The 4DSQ exhibits high internal consistency reliability and temporal stability across diverse clinical and cross-cultural cohorts.

Internal Consistency

Extensive field studies yield the following internal consistency metrics (Cronbach’s alpha, $\alpha$):

• Distress Scale (16 items): $\alpha = .90$ to $.94$, reflecting high homogeneity among general stress and demoralization indicators.
• Depression Scale (6 items): $\alpha = .82$ to $.90$, an exceptionally high internal consistency for a 6-item scale, attesting to the precise unidimensional focus on anhedonic depressive phenomena.
• Anxiety Scale (12 items): $\alpha = .79$ to $.88$, demonstrating solid internal coherence across diverse expressions of phobic, autonomic, and panic manifestations.
• Somatization Scale (16 items): $\alpha = .80$ to $.84$, which is remarkably high given that functional somatic symptoms stem from distinct organ systems (e.g., cardiopulmonary, gastrointestinal, musculoskeltal).

Test-Retest Reliability and Measurement Error

In stable clinical samples re-evaluated across a two-week interval without therapeutic changes, intraclass correlation coefficients (ICC) confirm high test-retest reproducibility:

• Distress: $\text{ICC} = 0.89$ to $0.92$
• Depression: $\text{ICC} = 0.84$ to $0.88$
• Anxiety: $\text{ICC} = 0.82$ to $0.86$
• Somatization: $\text{ICC} = 0.85$ to $0.89$

The Standard Error of Measurement (SEM) and Smallest Detectable Change (SDC) have been quantified for clinimetric application. At the individual patient level, changes of $ge 5$ points on the Distress scale, $ge 2$ points on the Depression scale, $ge 3$ points on the Anxiety scale, and $ge 4$ points on the Somatization scale exceed measurement error at the 95% confidence level, signifying true clinical change.

9. Factor Analysis

The dimensional validity of the 4DSQ has been examined through Exploratory Factor Analysis (EFA), Confirmatory Factor Analysis (CFA), and Item Response Theory (IRT) modeling.

Confirmatory Factor Analysis (CFA) Fit Indices

In the primary psychometric evaluation of the 4DSQ involving 2,127 patients (Terluin et al., 2006), maximum likelihood CFA corroborated the four-dimensional structure. Standard fit indices demonstrated that the hypothesized four-factor model fit the empirical data well:

• Comparative Fit Index (CFI): .94 to .96
• Tucker-Lewis Index (TLI): .94 to .95
• Root Mean Square Error of Approximation (RMSEA): .042 (95% CI: .040–.045)
• Standardized Root Mean Square Residual (SRMR): .048

Chi-square difference tests confirmed that this four-factor model was statistically superior to competing hierarchical models ($p < .001$), supporting the conceptualization that distress, depression, anxiety, and somatization represent distinct constructs rather than artifacts of a single undifferentiated psychological disturbance.

Factor Loadings

Standardized item factor loadings across all four latent factors are uniformly high and statistically significant ($p < .001$):

• Distress: Loadings range from .56 to .82. Items measuring core exhaustion and coping collapse (e.g., "that you can’t cope anymore" [$lambda = .82$], "tense" [$lambda = .78$], and "worry" [$lambda = .74$]) demonstrate the highest loadings.
• Depression: Factor loadings range from .68 to .89. The highest loadings are observed for "that life is not worth while" ($lambda = .89$) and "that everything is meaningless" ($lambda = .87$).
• Anxiety: Factor loadings range from .48 to .76. Somatosensory panic symptoms and overt irrational fears load most strongly, such as "anxiety or panic attacks" ($lambda = .76$) and "sudden fright for no reason" ($lambda = .72$).
• Somatization: Factor loadings range from .42 to .71. Musculoskeletal items (e.g., "neck pain" [$lambda = .65$], "painful muscles" [$lambda = .68$]) and autonomic arousal indicators (e.g., "palpitations" [$lambda = .67$], "dizziness" [$lambda = .63$]) display solid psychometric alignment.

Item Response Theory and Mokken Scale Analysis

Application of non-parametric IRT (Mokken scale analysis) and parametric polytomous IRT (Graded Response Model) confirmed that the 4DSQ scales form cumulative, unidimensional scales with Loevinger’s scalability coefficients ($H$) well above the standard psychometric threshold of .40 ($H_{\text{Distress}} = 0.52$; $H_{\text{Depression}} = 0.61$; $H_{\text{Anxiety}} = 0.46$; $H_{\text{Somatization}} = 0.41$), establishing moderate-to-strong scaling properties across all dimensions.

10. Instrument / Measurement Tool

The Four-Dimensional Symptom Questionnaire is an operationalized self-administered rating scale structured as follows:

• Test Type: Multidimensional self-report psychological symptom rating scale.
• Target Population: Adults (aged 18–65+) presenting in primary health care, occupational clinics, or general medical settings; also validated in non-clinical working populations.
• Completion Time: Approximately 5 to 10 minutes.
• Total Item Count: 50 items.
• Time Reference Window: "During the past week" (previous 7 days).
• Response Scale (Raw Format): 5-point ordinal frequency scale:
  • No
  • Sometimes
  • Regularly
  • Often
  • Very often or constantly
• Scoring Algorithm (3-Level Recoding Protocol): To reduce symptom magnification, minimize the influence of transient emotional amplification, and isolate persistent symptom presence, responses are recoded into a 3-point clinimetric scale prior to subscale summation:
  • "No" = 0 points
  • "Sometimes" = 1 point
  • "Regularly", "Often", or "Very often or constantly" = 2 points
• Subscale Item Composition:
  • Distress (16 items): Items 17, 19, 20, 22, 25, 26, 29, 32, 35, 36, 37, 38, 39, 41, 47, 48. Score range: 0 to 32.
  • Depression (6 items): Items 28, 30, 31, 33, 34, 46. Score range: 0 to 12.
  • Anxiety (12 items): Items 18, 21, 23, 24, 27, 40, 42, 43, 44, 45, 49, 50. Score range: 0 to 24.
  • Somatization (16 items): Items 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16. Score range: 0 to 32.
• Clinical Cut-Off Scores and Diagnostic Interpretation:
  • Distress (Range 0–32):
    • Low / Normal: 0 to 10 points (absence of significant psychological distress).
    • Moderately elevated: 11 to 20 points (indicates stress reaction, minor coping strain, or subclinical distress).
    • Strongly elevated: 21 to 32 points (indicates severe distress, substantial risk of functional impairment, sickness absence, or burnout).
  • Depression (Range 0–12):
    • Low / Normal: 0 to 2 points (depressive illness highly unlikely).
    • Moderately elevated: 3 to 5 points (possible depressive disorder; warrants detailed clinical interview).
    • Strongly elevated: 6 to 12 points (high probability of major depressive disorder; formal treatment indicated).
  • Anxiety (Range 0–24):
    • Low / Normal: 0 to 8 points (absence of specific anxiety disorder).
    • Moderately elevated: 9 to 12 points (indicates possible anxiety disorder or phobic tendency).
    • Strongly elevated: 13 to 24 points (indicates severe anxiety disorder; targeted cognitive behavioral therapy or pharmacotherapy indicated).
  • Somatization (Range 0–32):
    • Low / Normal: 0 to 10 points (normal somatic perception).
    • Moderately elevated: 11 to 20 points (indicates mild-to-moderate psychosomatic arousal).
    • Strongly elevated: 21 to 32 points (indicates substantial somatization, high bodily distress, or somatic symptom disorder).

11. Permissions & Fee and Test Year

The Four-Dimensional Symptom Questionnaire was formally published in its current 50-item psychometric structure in 2004 (for occupational applications) and 2006 (for comprehensive primary care validation) by Dr. Berend Terluin. The instrument is protected by international copyright held by Berend Terluin.

Licensing and Fee Policy: The 4DSQ is made available free of charge for non-commercial clinical practice and academic research. Clinicians, general practitioners, occupational physicians, and academic investigators are permitted to administer the scale, incorporate it into non-commercial medical records, and reproduce it for patient care without paying royalty fees. For commercial applications—including integration into proprietary electronic health records (EHR), fee-based digital health applications, commercial clinical trials funded by the pharmaceutical industry, or corporate consulting tools—written licensing authorization and fee arrangements must be established directly with the author.

The 4DSQ has been translated and culturally adapted into multiple international languages through standard forward-backward translation protocols, including English, Dutch, French, German, Polish, and Turkish. Official score sheets, translation files, and implementation guides are managed and distributed via Dr. Terluin’s academic resource repositories associated with Amsterdam UMC.

12. References

Clark, L. A., & Watson, D. (1991). Tripartite model of anxiety and depression: Psychometric evidence and taxonomic implications. Journal of Abnormal Psychology, 100(3), 316–336. https://doi.org/10.1037/0021-843X.100.3.316

Terluin, B., Brouwers, E. P. M., van Marwijk, H. W. J., Verhaak, P. F. M., & van der Horst, H. E. (2009). Detecting depressive and anxiety disorders in distressed patients in primary care; comparative diagnostic accuracy of the Four-Dimensional Symptom Questionnaire (4DSQ) and the Hospital Anxiety and Depression Scale (HADS). BMC Family Practice, 10, Article 58. https://doi.org/10.1186/1471-2296-10-58

Terluin, B., Smits, N., Brouwers, E. P. M., & de Vet, H. C. W. (2016). The Four-Dimensional Symptom Questionnaire (4DSQ) in the general population: normative data and cut-off points. BMC Psychiatry, 16, Article 208. https://doi.org/10.1186/s12888-016-0920-5

Terluin, B., Van Marwijk, H. W. J., Adèr, H. J., De Vet, H. C. W., Penninx, B. W. J. H., Hermens, M. L. M., Van Boeijen, C. A., Van Balkom, A. J. L. M., Van der Klink, J. J. L., & Stalman, W. A. B. (2006). The Four-Dimensional Symptom Questionnaire (4DSQ): a validation study of a multidimensional self-report questionnaire to assess distress, depression, anxiety and somatization. BMC Psychiatry, 6, Article 34. https://doi.org/10.1186/1471-244X-6-34

Terluin, B., Van Rhenen, W., Schaufeli, W. B., & De Haan, M. (2004). The Four-Dimensional Symptom Questionnaire (4DSQ): measuring distress and other mental health problems in a working population. Work & Stress, 18(3), 187–207. https://doi.org/10.1080/02678370412331270830

Ursin, H., & Eriksen, H. R. (2004). The cognitive activation theory of stress. Psychoneuroendocrinology, 29(5), 567–592. https://doi.org/10.1016/S0306-4530(03)00091-0

13. Items of the Scale (Questionnaire)